<SEC-DOCUMENT>0001085146-25-004384.txt : 20250731
<SEC-HEADER>0001085146-25-004384.hdr.sgml : 20250731
<ACCEPTANCE-DATETIME>20250731154659
ACCESSION NUMBER:		0001085146-25-004384
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250731
DATE AS OF CHANGE:		20250731

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IMMUNIC, INC.
		CENTRAL INDEX KEY:			0001280776
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				562358443
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88651
		FILM NUMBER:		251171436

	BUSINESS ADDRESS:	
		STREET 1:		1200 AVENUE OF THE AMERICAS
		STREET 2:		SUITE 200
		CITY:			NEW YORK
		STATE:			X1
		ZIP:			10036
		BUSINESS PHONE:		(332) 255-9818

	MAIL ADDRESS:	
		STREET 1:		1200 AVENUE OF THE AMERICAS
		STREET 2:		SUITE 200
		CITY:			NEW YORK
		STATE:			X1
		ZIP:			10036

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	VITAL THERAPIES INC
		DATE OF NAME CHANGE:	20040219

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aberdeen Group plc
		CENTRAL INDEX KEY:			0001716774
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		1 GEORGE STREET
		CITY:			EDINBURGH
		STATE:			X0
		ZIP:			EH2 2LL
		BUSINESS PHONE:		0131 245 2552

	MAIL ADDRESS:	
		STREET 1:		1 GEORGE STREET
		CITY:			EDINBURGH
		STATE:			X0
		ZIP:			EH2 2LL

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	abrdn plc
		DATE OF NAME CHANGE:	20210707

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Standard Life Aberdeen plc
		DATE OF NAME CHANGE:	20170912
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Aberdeen Group plc -->
          <cik>0001716774</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>common stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>06/30/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001280776</issuerCik>
        <issuerName>IMMUNIC, INC</issuerName>
        <issuerCusip>4525EP101</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>1200 AVENUE OF THE AMERICAS</com:street1>
          <com:street2>SUITE 200</com:street2>
          <com:city>NEW YORK</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10036</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Aberdeen Group plc</reportingPersonName>
      <citizenshipOrOrganization>X0</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>8243941.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>8243941.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>8243941.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>8.603</classPercent>
      <typeOfReportingPerson>HC</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>abrdn Inc</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>8243941.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>8243941.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>8243941.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>8.603</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>IMMUNIC, INC</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, NEW YORK 10036</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Aberdeen Group plc

abrdn Inc</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>1 George Street
Edinburgh, United Kingdom
EH2 2LL</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Aberdeen Group plc - UNITED KINGDOM

abrdn Inc - UNITED STATES</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>HC</typeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>8,243,941</amountBeneficiallyOwned>
        <classPercent>8.603</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>Aberdeen Group plc - 0

abrdn Inc - 0</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>Aberdeen Group plc - 8,243,941

abrdn Inc - 8,243,941</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>Aberdeen Group plc - 0

abrdn Inc - 0</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>Aberdeen Group plc - 8,243,941

abrdn Inc - 8,243,941</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>N</notApplicableFlag>
        <subsidiaryIdentificationAndClassification>See Exhibit</subsidiaryIdentificationAndClassification>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <exhibitInfo>Aberdeen Group plc
abrdn Holdings Limited
abrdn Inc.

Aberdeen Group plc is the parent company.
abrdn Holdings Limited is the intermediate holding company for abrdn Inc.
abrdn Inc. beneficially owns on behalf of our underlying clients 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G.</exhibitInfo>
    <signatureInformation>
      <reportingPersonName>Aberdeen Group plc</reportingPersonName>
      <signatureDetails>
        <signature>L.Beaton</signature>
        <title>Lyn Beaton, Major Shareholding Reporting Analyst</title>
        <date>07/31/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>abrdn Inc</reportingPersonName>
      <signatureDetails>
        <signature>L.Beaton</signature>
        <title>Lyn Beaton, Major Shareholding Reporting Analyst</title>
        <date>07/31/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
